Joaquín Serena
Joaquín Serena is an expert in Neurology at Hospital Universitari de Girona Doctor Josep Trueta (Spain). As of October 2026, ScienceLeadR ranks Joaquín Serena in the top 1% of experts worldwide for Cerebrovascular Disorders. Joaquín Serena has authored 309 publications, the most recent in 2026, and is an investigator in 21 clinical trials, 2 of them ongoing. SLR score: 838 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Cardiology - Surgery - Nutrition
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1996 - 2026
Number : 309
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Eicosapentaenoic acid blood status and outcomes in intracerebral haemorrhage. PMID 42659697 — mortality, hemorrhage, blood, hospital mortality, parenteral nutrition, enteral nutrition, eicosapentaenoic acid | Clin Nutr | 2026 | 0 |
| Temporal Profile of Soluble TLR4 and its Association with Intracerebral Haemorrhage Expansion. PMID 42474911 — stroke, enzyme-linked immunosorbent assay | Transl Stroke Res | 2026 | 0 |
| Adjunctive Intra-Arterial Alteplase After Successful Thrombectomy for Acute Ischemic Stroke: The CHOICE-2 Randomized Clinical Trial. PMID 42096239 — hemorrhage, ischemic stroke, stroke, tissue plasminogen activator, intracranial hemorrhages, thrombectomy | JAMA Top journal | 2026 | 0 |
| Glenzocimab Efficacy and Safety Added to Intravenous Thrombolysis With or Without Mechanical Thrombectomy in Patients With Acute Ischemic Stroke-ACTISAVE: A Prospective, Randomized, Double-Blind Study. PMID 42044230 — safety, hemorrhage, ischemic stroke, stroke, tissue plasminogen activator, double-blind method, cerebrovascular circulation, cerebrovascular disorders, therapeutics, blood platelets, thrombectomy | Stroke | 2026 | 0 |
| Chemical Optimization of Cerebral Embolectomy 2 (CHOICE 2) trial: study protocol. PMID 41339082 — embolectomy, stroke, tissue plasminogen activator, reperfusion | Stroke Vasc Neurol | 2025 | 0 |
Clinical Studies 21
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 7
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| BraiN20 Monitoring in Acute Stroke Undergoing Thrombectomy NCT06149754 — evoked potentials, reading, ischemic stroke, stroke, brain, magnetic resonance imaging, electrodes, recycling, arteries, evoked potentials, somatosensory, diagnosis, thrombectomy, prognosis, medical devices | N/A | Recruiting | 2023 |
| CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2) NCT05797792 — embolectomy, ischemic stroke, stroke, plasminogen, plasminogen activators, tissue plasminogen activator, reperfusion, tissues, thrombectomy | Phase 3 | Active not recruiting | 2023 |
LeadR Networks
Main global connection map